Search results
Andrew J. Conrad is an American geneticist who heads Verily, a life sciences division of Alphabet Inc. As its chief executive officer, Conrad has recruited a multidisciplinary team of chemists, doctors, engineers, behavioral scientists and data scientists to research health and disease.
Andrew Conrad, PhD, is the Chief Executive Officer, Chairman and Founder of Verily where he oversees an integrated team of engineers, scientists, designers, ...
Founder. Andy Conrad's vision for what would become Verily began in the Google X lab in Mountain View, California, as a moonshot. Having recently led groundbreaking work in the field of diagnostics as a molecular biologist and Chief Scientist at LabCorp, Andy joined the Google X team with the audacious goal to deliver a “10x change” in healthcare.
Andrew Conrad is the founder and CEO of Verily, an Alphabet company that applies technology to improve health outcomes. He is also the co-founder of Calico, a biotechnology company focused on aging and longevity.
25 de ago. de 2020 · Verily, Alphabet's health care company, is launching Coefficient Insurance Company, a stop-loss insurance provider backed by Swiss Re Group. Coefficient aims to use Verily's analytics and health tech to help employers control their costs and integrate with insurance companies.
Dr. Conrad is the Head of Google Life Sciences and a member of the Precision Medicine Initiative Working Group of the Advisory Committee to the Director. He has a background in genetics, biotechnology, and healthcare innovation.
Andrew Conrad is a healthcare entrepreneur and investor who leads Verily, a subsidiary of Alphabet. He also serves on the board of Genalyte, a biotech company, and advises SandboxAQ, an edtech startup.
